top | item 43917030

(no title)

djd20 | 9 months ago

I call bs... the utterly terrible customer experience is what lost them their customers. And constant changing of plans which became less and less effective... all of their 10$ a month customers don't suddenly have the budget to spend 1000$ a month on ozempic.

discuss

order

kotaKat|9 months ago

That’s why there’s all sorts of sketchy compounding pharmacies stepping up to the plate, not to mention the “research peptide” market…

doctorpangloss|9 months ago

> ... the past two years have been a fun experiment in semi-free-market medicine. I don’t mean the patent violations - it’s no surprise that you can sell drugs cheap if you violate the patent - I mean everything else. For the past three years, ~2 million people have taken complex peptides provided direct-to-consumer by a less-regulated supply chain, with barely a fig leaf of medical oversight, and it went great. There were no more side effects than any other medication. People who wanted to lose weight lost weight. And patients had a more convenient time than if they’d had to wait for the official supply chain to meet demand, get a real doctor, spend thousands of dollars on doctors’ visits, apply for insurance coverage, and go to a pharmacy every few weeks to pick up their next prescription.

https://news.ycombinator.com/item?id=43369502

sumtechguy|9 months ago

It has been interesting how that company managed to stay around.